Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Asset purchase
1.2.3 Assignment
1.2.4 Co-development
1.2.5 Co-market
1.2.6 Co-promotion
1.2.7 Collaborative R&D
1.2.8 Contract service
1.2.9 CRADA
1.2.10 Cross-licensing
1.2.11 Others
1.3 Market by Application
1.3.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Industry sector
1.3.3 Therapy areas
1.3.4 Technology type
1.3.5 Deal components
1.3.6 Financial terms
1.3.7 Stage of development
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Perspective (2018-2033)
2.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Growth Trends by Region
2.2.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Dynamics
2.3.1 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Industry Trends
2.3.2 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers
2.3.3 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
2.3.4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players by Revenue
3.1.1 Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players by Revenue (2018-2023)
3.1.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue
3.4 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Concentration Ratio
3.4.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue in 2022
3.5 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Key Players Head office and Area Served
3.6 Key Players Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Solution and Service
3.7 Date of Enter into Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Breakdown Data by Type
4.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Type (2024-2033)
5 Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Breakdown Data by Application
5.1 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
6.2 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023)
6.4 North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
7.2 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023)
7.4 Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
9.2 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023)
9.4 Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 1ST Biotherapeutics
11.1.1 1ST Biotherapeutics Company Detail
11.1.2 1ST Biotherapeutics Business Overview
11.1.3 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.1.4 1ST Biotherapeutics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.1.5 1ST Biotherapeutics Recent Development
11.2 3B Pharmaceuticals
11.2.1 3B Pharmaceuticals Company Detail
11.2.2 3B Pharmaceuticals Business Overview
11.2.3 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.2.4 3B Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.2.5 3B Pharmaceuticals Recent Development
11.3 3D-Micromac
11.3.1 3D-Micromac Company Detail
11.3.2 3D-Micromac Business Overview
11.3.3 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.3.4 3D-Micromac Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.3.5 3D-Micromac Recent Development
11.4 3DMed
11.4.1 3DMed Company Detail
11.4.2 3DMed Business Overview
11.4.3 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.4.4 3DMed Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.4.5 3DMed Recent Development
11.5 3D Systems
11.5.1 3D Systems Company Detail
11.5.2 3D Systems Business Overview
11.5.3 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.5.4 3D Systems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.5.5 3D Systems Recent Development
11.6 10X Genomics
11.6.1 10X Genomics Company Detail
11.6.2 10X Genomics Business Overview
11.6.3 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.6.4 10X Genomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.6.5 10X Genomics Recent Development
11.7 A*STAR Agency for Science
11.7.1 A*STAR Agency for Science Company Detail
11.7.2 A*STAR Agency for Science Business Overview
11.7.3 A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.7.4 A*STAR Agency for Science Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.7.5 A*STAR Agency for Science Recent Development
11.8 Technology and Research
11.8.1 Technology and Research Company Detail
11.8.2 Technology and Research Business Overview
11.8.3 Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.8.4 Technology and Research Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.8.5 Technology and Research Recent Development
11.9 A*STAR Institute of Microelectronics (IME)
11.9.1 A*STAR Institute of Microelectronics (IME) Company Detail
11.9.2 A*STAR Institute of Microelectronics (IME) Business Overview
11.9.3 A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.9.4 A*STAR Institute of Microelectronics (IME) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.9.5 A*STAR Institute of Microelectronics (IME) Recent Development
11.10 A2A Pharmaceuticals
11.10.1 A2A Pharmaceuticals Company Detail
11.10.2 A2A Pharmaceuticals Business Overview
11.10.3 A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.10.4 A2A Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.10.5 A2A Pharmaceuticals Recent Development
11.11 Abbvie
11.11.1 Abbvie Company Detail
11.11.2 Abbvie Business Overview
11.11.3 Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.11.4 Abbvie Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.11.5 Abbvie Recent Development
11.12 AbCellera
11.12.1 AbCellera Company Detail
11.12.2 AbCellera Business Overview
11.12.3 AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.12.4 AbCellera Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.12.5 AbCellera Recent Development
11.13 ABL Bio
11.13.1 ABL Bio Company Detail
11.13.2 ABL Bio Business Overview
11.13.3 ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.13.4 ABL Bio Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.13.5 ABL Bio Recent Development
11.14 Abpro
11.14.1 Abpro Company Detail
11.14.2 Abpro Business Overview
11.14.3 Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.14.4 Abpro Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.14.5 Abpro Recent Development
11.15 Academy of Military Medical Sciences (China)
11.15.1 Academy of Military Medical Sciences (China) Company Detail
11.15.2 Academy of Military Medical Sciences (China) Business Overview
11.15.3 Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.15.4 Academy of Military Medical Sciences (China) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.15.5 Academy of Military Medical Sciences (China) Recent Development
11.16 Accellix
11.16.1 Accellix Company Detail
11.16.2 Accellix Business Overview
11.16.3 Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.16.4 Accellix Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.16.5 Accellix Recent Development
11.17 Accord Healthcare
11.17.1 Accord Healthcare Company Detail
11.17.2 Accord Healthcare Business Overview
11.17.3 Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.17.4 Accord Healthcare Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.17.5 Accord Healthcare Recent Development
11.18 AccuGenomics
11.18.1 AccuGenomics Company Detail
11.18.2 AccuGenomics Business Overview
11.18.3 AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.18.4 AccuGenomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.18.5 AccuGenomics Recent Development
11.19 ACEA Biosciences
11.19.1 ACEA Biosciences Company Detail
11.19.2 ACEA Biosciences Business Overview
11.19.3 ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.19.4 ACEA Biosciences Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.19.5 ACEA Biosciences Recent Development
11.20 AC Immune
11.20.1 AC Immune Company Detail
11.20.2 AC Immune Business Overview
11.20.3 AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.20.4 AC Immune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.20.5 AC Immune Recent Development
11.21 Acoustic MedSystems
11.21.1 Acoustic MedSystems Company Detail
11.21.2 Acoustic MedSystems Business Overview
11.21.3 Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.21.4 Acoustic MedSystems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.21.5 Acoustic MedSystems Recent Development
11.22 Adaptimmune
11.22.1 Adaptimmune Company Detail
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.22.4 Adaptimmune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.22.5 Adaptimmune Recent Development
11.23 Aduro BioTech
11.23.1 Aduro BioTech Company Detail
11.23.2 Aduro BioTech Business Overview
11.23.3 Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.23.4 Aduro BioTech Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.23.5 Aduro BioTech Recent Development
11.24 Advaxis
11.24.1 Advaxis Company Detail
11.24.2 Advaxis Business Overview
11.24.3 Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.24.4 Advaxis Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.24.5 Advaxis Recent Development
11.25 Adventus Ventures
11.25.1 Adventus Ventures Company Detail
11.25.2 Adventus Ventures Business Overview
11.25.3 Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.25.4 Adventus Ventures Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.25.5 Adventus Ventures Recent Development
11.26 Aerolase
11.26.1 Aerolase Company Detail
11.26.2 Aerolase Business Overview
11.26.3 Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Introduction
11.26.4 Aerolase Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
11.26.5 Aerolase Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Asset purchase
Table 3. Key Players of Assignment
Table 4. Key Players of Co-development
Table 5. Key Players of Co-market
Table 6. Key Players of Co-promotion
Table 7. Key Players of Collaborative R&D
Table 8. Key Players of Contract service
Table 9. Key Players of CRADA
Table 10. Key Players of Cross-licensing
Table 11. Key Players of Others
Table 12. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2018-2023)
Table 16. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 17. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2024-2033)
Table 18. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Trends
Table 19. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Drivers
Table 20. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Challenges
Table 21. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Restraints
Table 22. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Players (2018-2023)
Table 24. Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2022)
Table 25. Ranking of Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Companies by Revenue (US$ Million) in 2022
Table 26. Global 5 Largest Players Market Share by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product Solution and Service
Table 29. Date of Enter into Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2018-2023)
Table 33. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 34. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Type (2024-2033)
Table 35. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2018-2023)
Table 37. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 38. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue Market Share by Application (2024-2033)
Table 39. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 45. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 46. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 47. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 48. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 50. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 51. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 52. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 53. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 54. 1ST Biotherapeutics Company Detail
Table 55. 1ST Biotherapeutics Business Overview
Table 56. 1ST Biotherapeutics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 57. 1ST Biotherapeutics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 58. 1ST Biotherapeutics Recent Development
Table 59. 3B Pharmaceuticals Company Detail
Table 60. 3B Pharmaceuticals Business Overview
Table 61. 3B Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 62. 3B Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 63. 3B Pharmaceuticals Recent Development
Table 64. 3D-Micromac Company Detail
Table 65. 3D-Micromac Business Overview
Table 66. 3D-Micromac Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 67. 3D-Micromac Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 68. 3D-Micromac Recent Development
Table 69. 3DMed Company Detail
Table 70. 3DMed Business Overview
Table 71. 3DMed Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 72. 3DMed Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 73. 3DMed Recent Development
Table 74. 3D Systems Company Detail
Table 75. 3D Systems Business Overview
Table 76. 3D Systems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 77. 3D Systems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 78. 3D Systems Recent Development
Table 79. 10X Genomics Company Detail
Table 80. 10X Genomics Business Overview
Table 81. 10X Genomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 82. 10X Genomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 83. 10X Genomics Recent Development
Table 84. A*STAR Agency for Science Company Detail
Table 85. A*STAR Agency for Science Business Overview
Table 86. A*STAR Agency for Science Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 87. A*STAR Agency for Science Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 88. A*STAR Agency for Science Recent Development
Table 89. Technology and Research Company Detail
Table 90. Technology and Research Business Overview
Table 91. Technology and Research Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 92. Technology and Research Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 93. Technology and Research Recent Development
Table 94. A*STAR Institute of Microelectronics (IME) Company Detail
Table 95. A*STAR Institute of Microelectronics (IME) Business Overview
Table 96. A*STAR Institute of Microelectronics (IME) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 97. A*STAR Institute of Microelectronics (IME) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 98. A*STAR Institute of Microelectronics (IME) Recent Development
Table 99. A2A Pharmaceuticals Company Detail
Table 100. A2A Pharmaceuticals Business Overview
Table 101. A2A Pharmaceuticals Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 102. A2A Pharmaceuticals Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 103. A2A Pharmaceuticals Recent Development
Table 104. Abbvie Company Detail
Table 105. Abbvie Business Overview
Table 106. Abbvie Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 107. Abbvie Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 108. Abbvie Recent Development
Table 109. AbCellera Company Detail
Table 110. AbCellera Business Overview
Table 111. AbCellera Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 112. AbCellera Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 113. AbCellera Recent Development
Table 114. ABL Bio Company Detail
Table 115. ABL Bio Business Overview
Table 116. ABL Bio Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 117. ABL Bio Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 118. ABL Bio Recent Development
Table 119. Abpro Company Detail
Table 120. Abpro Business Overview
Table 121. Abpro Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 122. Abpro Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 123. Abpro Recent Development
Table 124. Academy of Military Medical Sciences (China) Company Detail
Table 125. Academy of Military Medical Sciences (China) Business Overview
Table 126. Academy of Military Medical Sciences (China) Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 127. Academy of Military Medical Sciences (China) Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 128. Academy of Military Medical Sciences (China) Recent Development
Table 129. Accellix Company Detail
Table 130. Accellix Business Overview
Table 131. Accellix Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 132. Accellix Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 133. Accellix Recent Development
Table 134. Accord Healthcare Company Detail
Table 135. Accord Healthcare Business Overview
Table 136. Accord Healthcare Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 137. Accord Healthcare Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 138. Accord Healthcare Recent Development
Table 139. AccuGenomics Company Detail
Table 140. AccuGenomics Business Overview
Table 141. AccuGenomics Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 142. AccuGenomics Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 143. AccuGenomics Recent Development
Table 144. ACEA Biosciences Company Detail
Table 145. ACEA Biosciences Business Overview
Table 146. ACEA Biosciences Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 147. ACEA Biosciences Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 148. ACEA Biosciences Recent Development
Table 149. AC Immune Company Detail
Table 150. AC Immune Business Overview
Table 151. AC Immune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 152. AC Immune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 153. AC Immune Recent Development
Table 154. Acoustic MedSystems Company Detail
Table 155. Acoustic MedSystems Business Overview
Table 156. Acoustic MedSystems Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 157. Acoustic MedSystems Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 158. Acoustic MedSystems Recent Development
Table 159. Adaptimmune Company Detail
Table 160. Adaptimmune Business Overview
Table 161. Adaptimmune Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 162. Adaptimmune Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 163. Adaptimmune Recent Development
Table 164. Aduro BioTech Company Detail
Table 165. Aduro BioTech Business Overview
Table 166. Aduro BioTech Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 167. Aduro BioTech Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 168. Aduro BioTech Recent Development
Table 169. Advaxis Company Detail
Table 170. Advaxis Business Overview
Table 171. Advaxis Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 172. Advaxis Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 173. Advaxis Recent Development
Table 174. Adventus Ventures Company Detail
Table 175. Adventus Ventures Business Overview
Table 176. Adventus Ventures Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 177. Adventus Ventures Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 178. Adventus Ventures Recent Development
Table 179. Aerolase Company Detail
Table 180. Aerolase Business Overview
Table 181. Aerolase Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Product
Table 182. Aerolase Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023) & (US$ Million)
Table 183. Aerolase Recent Development
Table 184. Research Programs/Design for This Report
Table 185. Key Data Information from Secondary Sources
Table 186. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Asset purchase Features
Figure 4. Assignment Features
Figure 5. Co-development Features
Figure 6. Co-market Features
Figure 7. Co-promotion Features
Figure 8. Collaborative R&D Features
Figure 9. Contract service Features
Figure 10. CRADA Features
Figure 11. Cross-licensing Features
Figure 12. Others Features
Figure 13. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 14. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Application: 2022 VS 2033
Figure 15. Industry sector Case Studies
Figure 16. Therapy areas Case Studies
Figure 17. Technology type Case Studies
Figure 18. Deal components Case Studies
Figure 19. Financial terms Case Studies
Figure 20. Stage of development Case Studies
Figure 21. Others Case Studies
Figure 22. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Report Years Considered
Figure 23. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 24. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 25. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region: 2022 VS 2033
Figure 26. Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Players in 2022
Figure 27. Global Top Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics as of 2022)
Figure 28. The Top 10 and 5 Players Market Share by Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Revenue in 2022
Figure 29. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. North America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 31. United States Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Canada Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Europe Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 35. Germany Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. France Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. U.K. Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Italy Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Russia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Nordic Countries Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Region (2018-2033)
Figure 43. China Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Japan Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Latin America Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 51. Mexico Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Brazil Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Middle East & Africa Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Share by Country (2018-2033)
Figure 55. Turkey Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. 1ST Biotherapeutics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 58. 3B Pharmaceuticals Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 59. 3D-Micromac Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 60. 3DMed Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 61. 3D Systems Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 62. 10X Genomics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 63. A*STAR Agency for Science Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 64. Technology and Research Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 65. A*STAR Institute of Microelectronics (IME) Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 66. A2A Pharmaceuticals Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 67. Abbvie Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 68. AbCellera Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 69. ABL Bio Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 70. Abpro Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 71. Academy of Military Medical Sciences (China) Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 72. Accellix Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 73. Accord Healthcare Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 74. AccuGenomics Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 75. ACEA Biosciences Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 76. AC Immune Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 77. Acoustic MedSystems Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 78. Adaptimmune Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 79. Aduro BioTech Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 80. Advaxis Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 81. Adventus Ventures Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 82. Aerolase Revenue Growth Rate in Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed